Sanae Lembirik

Broadly neutralizing antibodies target the coronavirus fusion peptide

Peter D. Crompton, J. Mascola, J. Yewdell, 2022, bioRxiv.

In Vitro and In Vivo Characterization of Tebipenem, an Orally Active Carbapenem, against Biothreat Pathogens

M. Pucci, Akash Jain, Nicholas P Clayton, 2021, Antimicrobial Agents and Chemotherapy.

Broadly neutralizing antibodies target the coronavirus fusion peptide

Peter D. Crompton, J. Mascola, J. Yewdell, 2022, Science.

Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses

Peter D. Crompton, J. Mascola, J. Yewdell, 2022, Cell Host & Microbe.

Efficacy of delafloxacin against the biothreat pathogen Bacillus anthracis.

C. Klimko, C. Cote, M. Hickman, 2023, The Journal of antimicrobial chemotherapy.

In vitro and in vivo activity of GT-1, a novel siderophore cephalosporin, and GT-055, a broad-spectrum β-lactamase inhibitor, against biothreat and ESKAPE pathogens

R. Panchal, D. Biek, Stephanie A. Halasohoris, 2021, The Journal of Antibiotics.